Global Myopia and Presbyopia Treatment Market 2023-2027

Description

List of Tables

The myopia and presbyopia treatment market is forecasted to grow by USD 7946.29 mn during 2022-2027, accelerating at a CAGR of 8.09% during the forecast period. The report on the myopia and presbyopia treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of myopia and presbyopia, rising awareness regarding vision care, and growing demand for vision correction among the aging population.

Technavio's myopia and presbyopia treatment market is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	7.71%
CAGR	8.09%
Incremental Value	$7,946.29mn

By Type

Myopia treatment
Presbyopia treatment

By Product

Lenses and glass
Surgery
Drug

By Geographical Landscape

Asia
North America
Europe
Rest of World (ROW)

This study identifies the recent developments in myopia and presbyopia treatment as one of the prime reasons driving the myopia and presbyopia treatment market growth during the next few years. Also, increasing medical tourism for low-cost ophthalmology surgeries and emergence of multifocal intraocular lenses will lead to sizable demand in the market.

The report on the myopia and presbyopia treatment market covers the following areas:

Myopia and presbyopia treatment market sizing
Myopia and presbyopia treatment market forecast
Myopia and presbyopia treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading myopia and presbyopia treatment market vendors that include AbbVie Inc., Alcon Inc., Arctic Vision, Bausch Health Companies Inc., BVI Holdings Ltd., Carl Zeiss AG, ENTOD INTERNATIONAL, EssilorLuxottica, F. Hoffmann La Roche Ltd., Johnson and Johnson, Metall Zug AG, NIDEK Co. Ltd., Ophtec BV, Orasis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Sanjeevan School For Perfect Eyesight, Sydnexis Inc., The Cooper Companies Inc., Topcon Corp., Vision Care Group, Visus Therapeutics Inc., Ziemer Ophthalmic Systems AG, and Evotec SE. Also, the myopia and presbyopia treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR74159

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global myopia and presbyopia treatment market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global myopia and presbyopia treatment market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Myopia treatment - Market size and forecast 2022-2027
Exhibit 34: Chart on Myopia treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Myopia treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Myopia treatment - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Myopia treatment - Year-over-year growth 2022-2027 (%)
6.4 Presbyopia treatment - Market size and forecast 2022-2027
Exhibit 38: Chart on Presbyopia treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Presbyopia treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Presbyopia treatment - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Presbyopia treatment - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 44: Chart on Product - Market share 2022-2027 (%)
Exhibit 45: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 46: Chart on Comparison by Product
Exhibit 47: Data Table on Comparison by Product
7.3 Lenses and glass - Market size and forecast 2022-2027
Exhibit 48: Chart on Lenses and glass - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Lenses and glass - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Lenses and glass - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Lenses and glass - Year-over-year growth 2022-2027 (%)
7.4 Surgery - Market size and forecast 2022-2027
Exhibit 52: Chart on Surgery - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Surgery - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Surgery - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Surgery - Year-over-year growth 2022-2027 (%)
7.5 Drug - Market size and forecast 2022-2027
Exhibit 56: Chart on Drug - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Drug - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Drug - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Drug - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Product
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2022-2027
Exhibit 67: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.4 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 111: AbbVie Inc. - Overview
Exhibit 112: AbbVie Inc. - Product / Service
Exhibit 113: AbbVie Inc. - Key news
Exhibit 114: AbbVie Inc. - Key offerings
12.4 Alcon Inc.
Exhibit 115: Alcon Inc. - Overview
Exhibit 116: Alcon Inc. - Business segments
Exhibit 117: Alcon Inc. - Key offerings
Exhibit 118: Alcon Inc. - Segment focus
12.5 Bausch Health Companies Inc.
Exhibit 119: Bausch Health Companies Inc. - Overview
Exhibit 120: Bausch Health Companies Inc. - Business segments
Exhibit 121: Bausch Health Companies Inc. - Key news
Exhibit 122: Bausch Health Companies Inc. - Key offerings
Exhibit 123: Bausch Health Companies Inc. - Segment focus
12.6 BVI Holdings Ltd.
Exhibit 124: BVI Holdings Ltd. - Overview
Exhibit 125: BVI Holdings Ltd. - Product / Service
Exhibit 126: BVI Holdings Ltd. - Key offerings
12.7 Carl Zeiss AG
Exhibit 127: Carl Zeiss AG - Overview
Exhibit 128: Carl Zeiss AG - Business segments
Exhibit 129: Carl Zeiss AG - Key offerings
Exhibit 130: Carl Zeiss AG - Segment focus
12.8 EssilorLuxottica
Exhibit 131: EssilorLuxottica - Overview
Exhibit 132: EssilorLuxottica - Business segments
Exhibit 133: EssilorLuxottica - Key offerings
Exhibit 134: EssilorLuxottica - Segment focus
12.9 Johnson and Johnson
Exhibit 135: Johnson and Johnson - Overview
Exhibit 136: Johnson and Johnson - Business segments
Exhibit 137: Johnson and Johnson - Key news
Exhibit 138: Johnson and Johnson - Key offerings
Exhibit 139: Johnson and Johnson - Segment focus
12.10 Metall Zug AG
Exhibit 140: Metall Zug AG - Overview
Exhibit 141: Metall Zug AG - Business segments
Exhibit 142: Metall Zug AG - Key offerings
Exhibit 143: Metall Zug AG - Segment focus
12.11 NIDEK Co. Ltd.
Exhibit 144: NIDEK Co. Ltd. - Overview
Exhibit 145: NIDEK Co. Ltd. - Business segments
Exhibit 146: NIDEK Co. Ltd. - Key offerings
Exhibit 147: NIDEK Co. Ltd. - Segment focus
12.12 Ophtec BV
Exhibit 148: Ophtec BV - Overview
Exhibit 149: Ophtec BV - Product / Service
Exhibit 150: Ophtec BV - Key offerings
12.13 Orasis Pharmaceuticals Inc.
Exhibit 151: Orasis Pharmaceuticals Inc. - Overview
Exhibit 152: Orasis Pharmaceuticals Inc. - Product / Service
Exhibit 153: Orasis Pharmaceuticals Inc. - Key offerings
12.14 Regeneron Pharmaceuticals Inc.
Exhibit 154: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 155: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 156: Regeneron Pharmaceuticals Inc. - Key offerings
12.15 Sydnexis Inc.
Exhibit 157: Sydnexis Inc. - Overview
Exhibit 158: Sydnexis Inc. - Product / Service
Exhibit 159: Sydnexis Inc. - Key offerings
12.16 Topcon Corp.
Exhibit 160: Topcon Corp. - Overview
Exhibit 161: Topcon Corp. - Business segments
Exhibit 162: Topcon Corp. - Key news
Exhibit 163: Topcon Corp. - Key offerings
Exhibit 164: Topcon Corp. - Segment focus
12.17 Ziemer Ophthalmic Systems AG
Exhibit 165: Ziemer Ophthalmic Systems AG - Overview
Exhibit 166: Ziemer Ophthalmic Systems AG - Product / Service
Exhibit 167: Ziemer Ophthalmic Systems AG - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
13.5 List of abbreviations
Exhibit 174: List of abbreviations